Zobrazeno 1 - 10 of 316 pro vyhledávání: '"K Wachtell"'
1
Incident atrial fibrillation and heart failure in treated hypertensive patients with left ventricular hypertrophy
Autor: C Bang, A Greve, L Kober, A Muthiah, S Kjeldsen, S Julius, K Wachtell, R B Devereux, P Okin
Publikováno v: European Heart Journal. 43
Background Hypertension and left ventricular hypertrophy (LVH) are predictors of atrial fibrillation (AF) and heart failure (HF). The incidence rates of AF and HF and especially the combination of these two complications in hypertensive patients with
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3d55664e82959c2975d409aa3be01d07
https://doi.org/10.1093/eurheartj/ehac544.2172
Zobrazit plný text záznamu
2
High-sensitive Troponin T is not associated with the progression of asymptomatic mild to moderate aortic stenosis: a post hoc substudy of the SEAS trial
Autor: E Hadziselimovic, A M Greve, A Sajadieh, M H Olsen, Y A Kesaniemi, C A Nienaber, S G Ray, A B Rossebo, R Willenheimer, K Wachtell, O W Nielsen
Publikováno v: European Heart Journal. 43
Background Aortic stenosis (AS) and coronary artery disease (CAD) share pathophysiological pathways, as reflected by frequent concomitant revascularization in patients undergoing aortic valve replacement (AVR). High-sensitive Troponin T (hsTnT) is a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3843e6aa6fcbb939c93019c3e5c5f12c
https://doi.org/10.1093/eurheartj/ehac544.2291
Zobrazit plný text záznamu
3
Left atrial systolic force in hypertensive patients with left ventricular hypertrophy predicts atrial fibrillation
Autor: C Bang, L Gerholt, E Gerdts, A C Larstorp, S Kjeldsen, S Julius, K Wachtell, P Okin, R B Devereux
Publikováno v: European Heart Journal. 43
Background Recently increased left atrial systolic force (LASF), a measure of left atrial function, has been associated with left ventricular hypertrophy (LVH) in hypertensive patients. Impaired left ventricular relaxation is often seen in hypertensi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7753322c6efd671841d74910b03e8d1b
https://doi.org/10.1093/eurheartj/ehac544.2174
Zobrazit plný text záznamu
4
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis
Autor: Milad Nazarzadeh, Zeinab Bidel, Dexter Canoy, Emma Copland, Derrick A Bennett, Abbas Dehghan, George Davey Smith, Rury R Holman, Mark Woodward, Ajay Gupta, Amanda I Adler, Malgorzata Wamil, Naveed Sattar, William C Cushman, Richard J McManus, Koon Teo, Barry R Davis, John Chalmers, Carl J Pepine, Kazem Rahimi, L Agodoa, A Algra, F W Asselbergs, N Beckett, E Berge, H Black, F P J Brouwers, M Brown, C J Bulpitt, B Byington, J Cutler, R B Devereaux, J Dwyer, R Estacio, R Fagard, K Fox, T Fukui, Y Imai, M Ishii, S Julius, Y Kanno, S E Kjeldsen, J Kostis, K Kuramoto, J Lanke, E Lewis, J Lewis, M Lievre, L H Lindholm, S Lueders, S MacMahon, G Mancia, M Matsuzaki, M H Mehlum, S Nissen, H Ogawa, T Ogihara, T Ohkubo, C Palmer, A Patel, M Pfeffer, N R Poulter, H Rakugi, G Reboldi, C Reid, G Remuzzi, P Ruggenenti, T Saruta, J Schrader, R Schrier, P Sever, P Sleight, J A Staessen, H Suzuki, L Thijs, K Ueshima, S Umemoto, W H van Gilst, P Verdecchia, K Wachtell, P Whelton, L Wing, Y Yui, S Yusuf, A Zanchetti, Z Y Zhang, C Anderson, C Baigent, BM Brenner, R Collins, D de Zeeuw, J Lubsen, E Malacco, B Neal, V Perkovic, B Pitt, A Rodgers, P Rothwell, G Salimi-Khorshidi, J Sundström, F Turnbull, G Viberti, J Wang
Publikováno v: Nazarzadeh, M, Bidel, Z, Canoy, D, Copland, E, Bennett, D A, Dehghan, A, Davey Smith, G, Holman, R R, Woodward, M, Gupta, A, Adler, A I, Wamil, M, Sattar, N, Cushman, W C, McManus, R J, Koon, T, Davis, B R, Chalmers, J, Pepine, C J & Rahimi, K 2022, ' Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes : an individual participant-level data meta-analysis ', Lancet Diabetes and Endocrinology, vol. 10, no. 9, pp. 645-654 . https://doi.org/10.1016/S2213-8587(22)00172-3
Background Controversy exists as to whether the threshold for blood pressure-lowering treatment should differ between people with and without type 2 diabetes. We aimed to investigate the effects of blood pressure-lowering treatment on the risk of maj
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44422d6b20717ea24c63a10d59c54203
https://pubmed.ncbi.nlm.nih.gov/36427521
Zobrazit plný text záznamu
5
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis
Autor: Emma Copland, Dexter Canoy, Milad Nazarzadeh, Zeinab Bidel, Rema Ramakrishnan, Mark Woodward, John Chalmers, Koon K Teo, Carl J Pepine, Barry R Davis, Sverre Kjeldsen, Johan Sundström, Kazem Rahimi, A Adler, L Agodoa, A Algra, F W Asselbergs, N Beckett, E Berge, H Black, F P J Brouwers, M Brown, C J Bulpitt, B Byington, J Chalmers, W C Cushman, J Cutler, B R Davis, R B Devereaux, J Dwyer, R Estacio, R Fagard, K Fox, T Fukui, A K Gupta, R R Holman, Y Imai, M Ishii, S Julius, Y Kanno, S E Kjeldsen, J Kostis, K Kuramoto, J Lanke, E Lewis, J Lewis, M Lievre, L H Lindholm, S Lueders, S MacMahon, G Mancia, M Matsuzaki, M H Mehlum, S Nissen, H Ogawa, T Ogihara, T Ohkubo, C Palmer, A Patel, C J Pepine, M Pfeffer, N R Poulter, H Rakugi, G Reboldi, C Reid, G Remuzzi, P Ruggenenti, T Saruta, J Schrader, R Schrier, P Sever, P Sleight, J A Staessen, H Suzuki, L Thijs, K Ueshima, S Umemoto, W H van Gilst, P Verdecchia, K Wachtell, P Whelton, L Wing, M Woodward, Y Yui, S Yusuf, A Zanchetti, Z Y Zhang, C Anderson, C Baigent, BM Brenner, R Collins, D de Zeeuw, J Lubsen, E Malacco, B Neal, V Perkovic, B Pitt, A Rodgers, P Rothwell, G Salimi-Khorshidi, J Sundström, F Turnbull, G Viberti, J Wang
Findings 33 trials met the inclusion criteria, and included 260 447 participants with 15 012 cancer events. Median follow-up of included participants was 4?2 years (IQR 3?0?5?0). In the individual participant data meta-analysis comparing each drug cl
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03bf241456fba8c60d821c06d95aca03
http://hdl.handle.net/10044/1/89099
Zobrazit plný text záznamu
6
P3835Improvement of myocardial energetic efficiency during treatment in hypertensive patients: the life study
Autor: Anders M. Greve, K. Wachtell, Costantino Mancusi, G. De Simone, M A Losi, Sverre E. Kjeldsen, Eva Gerdts, Richard B. Devereux
Publikováno v: European Heart Journal. 40
Background Myocardial energetic efficiency (MEE) per unit of left ventricular (LV) mass significantly predicts composite of cardiovascular (CV) events in treated hypertensive patients and specifically heart failure in an event-free population-based c
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9020e426de67bb520a08fb6de9afce76
https://doi.org/10.1093/eurheartj/ehz745.0676
Zobrazit plný text záznamu
9
A prediction of the renal and cardiovascular efficacy of aliskiren in ALTITUDE using short-term changes in multiple risk markers
Autor: H. J. Lambers Heerspink, D. E. Grobbee, Jarno Hoekman, Marinus J.C. Eijkemans, Paul A. Smink, H Ibsen, K. Wachtell, Dick de Zeeuw, Frederik Persson, H. H. Parving, Lars H Lindholm
Publikováno v: European Journal of Preventive Cardiology, 21(4), 434-441. SAGE Publications Inc.
INTRODUCTION: We recently developed and validated in existing trials a novel algorithm (PRE score) to predict long-term drug efficacy based on short-term (month-6) drug-induced changes in multiple risk markers. To show the value of the PRE score for
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfcae926b9c54903f6f5d911d71f8223
https://doi.org/10.1177/2047487313481754
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje